Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment Novamind Inc. (CSE:NM) (“Novamind”), a
Read MoreCedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment Novamind Inc. (CSE:NM) (“Novamind”), a
Read More